Array BioPharma (Boulder) announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs). 

OrPro Therapeutics, Inc. (San Diego) announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).  

Covidien (Boulder) announced the U.S. Food and Drug Administration (FDA) has granted the Company 510(k) clearance to market the Covidien Nellcor™ Bedside SpO2 Patient Monitoring System. The new patient monitoring system is now available for sale in the U.S. The Nellcor Bedside SpO2 system with OxiMax™ technology continuously monitors SpO2 and pulse rate for adult, pediatric and neonatal patients, giving clinicians instant access to comprehensive trending respiratory information. This enables clinicians to detect subtle, yet critical, heart rate and SpO2 variations earlier and thus address respiratory complications sooner.  

AspenBio Pharma, Inc. (Castle Rock) announced that it has executed an exclusive worldwide license agreement with a major international animal health company, providing license and sub-license rights to AspenBio's entire animal health portfolio. Under the license agreement AspenBio will receive license fees of approximately $1.0 million and milestone payments totaling $2.0 million tied to specified development and regulatory achievements and royalties on licensed product sales. An additional $2.0 million in milestone payments is potentially payable under the agreement associated with expanded development and commercialization efforts by the licensee.  

BURNS MARKETING ACQUIRES DENVER-BASED RIPCORD BRANDING AND MARKETING COMMUNICATIONS FIRM 

Denver Business Journal 

Colorado sees steady uptick in device companies since 2001 

Holli Riebel has been named chief operating officer of the Denver Metro Chamber of Commerce, effective Aug. 19
DenverBusiness Journal  

Colorado’s bioscience industry expects good things from reforms of U.S. Food and Drug Administration (FDA) regulations signed into law July 13.
Denver Business Journal 

Denver Metro Chamber names Riebel its new chief operating officer
The Denver Post